Expression of the RNA-binding protein HuR and its clinical significance in human stage I and II lung adenocarcinoma

Histology and Histopathology

Volumn 27, Issue 5, 2012, Pages 617-626

  Lauriola, Libero ^a   Granone, Pierluigi ^a   Ramella, Sara ^b   Lanza, Paola ^a   Ranelletti, Franco Oreste ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Human lung adenocarcinoma; HuR expression; Immunohistochemistry

Indexed keywords

HU ANTIGEN;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CELL NUCLEUS; CYTOPLASM; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LUNG TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CELL NUCLEUS; CYTOPLASM; DISEASE-FREE SURVIVAL; FEMALE; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; YOUNG ADULT;

EID: 84859331650     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Antic D. and Keene J.D. (1997). Embryonic lethal abnormal visual RNAbinding proteins involved in growth, differentiation, and posttranscriptional gene expression. Am. J. Hum. Genet. 61, 273-278.
2. Blaxall B.C., Dwyer-Nield L.D., Bauer A.K., Bohlmeyer T.J., Malkinson A.M. and Port J.D. (2000). Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol. Carcinog. 28, 76-83.
3. Brennan C.M. and Steitz J.A. (2001). HuR and mRNA stability. Cell. Mol. Life. Sci. 58, 266-277.
4. Brennan C.M., Gallouzi I.E. and Steitz J.A. (2000). Protein ligands to HuR modulate its interaction with target mRNAs in vivo. J. Cell Biol. 151, 1-14.
5. Costantino C.L., Witkiewicz A.K., Kuwano Y., Cozzitorto J.A., Kennedy E.P., Dasgupta A., Keen J.C., Yeo C.J., Gorospe M. and Brody J.R. (2009). The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase. Cancer Res. 69, 4567-4572.
6. Denkert C., Weichert W., Pest S., Koch I., Licht D., Köbel M., Reles A., Sehouli J., Dietel M. and Hauptmann S. (2004). Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res. 64, 189-195.
7. Denkert C., Koch I., von Keyserlingk N., Noske A., Niesporek S., Dietel M. and Weichert W. (2006). Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod. Pathol. 19, 1261-1269.
8. Fan X.C. and Steitz J.A. (1998a). Overexpression of HuR, a nuclear- cytoplasmic shuttling protein, increases the in vivo stability of AREcontaining mRNAs. EMBO J. 17, 3448-3460.
9. Fan X.C. and Steitz J.A. (1998b). HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc. Natl. Acad. Sci. USA 95, 15293-15298.
10. Gallouzi I.E., Brennan C.M. and Steitz J.A. (2001). Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock. RNA 7, 1348-1361.
11. Gazdar A.F. and Minna J.D. (1997). Cigarettes, sex, and lung adenocarcinoma. J. Natl. Cancer Inst. 89, 1563-1565.
12. Hasegawa H., Kakuguchi W., Kuroshima T., Kitamura T., Tanaka S., Kitagawa Y., Totsuka Y., Shindoh M. and Higashino F. (2009). HuR is exported to the cytoplasm in oral cancer cells in a different manner from that of normal cells. Brit. J. Cancer 100, 1943-1948.
13. Hastings R.H. (2004). Parathyroid hormone-related protein and lung biology. Resp. Physiol. Neurobiol. 142, 95-113.
14. Heinonen M., Bono P., Narko K., Chang S.H., Lundin J., Joensuu H., Furneaux H., Hla T., Haglund G. and Ristimaki A. (2005). Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res. 65, 2157-2161.
15. Herbst R.S., Heymach J.V. and Lippman S.M. (2008). Lung cancer. New Engl. J. Med. 359, 1367-1380.
16. Hinmana M.N. and Loua H. (2008). Diverse molecular functions of Hu proteins. Cell. Mol. Life. Sci. 65, 3168-3181.
17. Keene J.D. (1999). Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc. Natl. Acad. Sci. USA 96, 5-7.
18. López de Silanes I., Fan J., Yang X., Potapova O., Zonderman A.B., Pizer E.S. and Gorospe M. (2003). Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 22, 7146-7154.
19. López de Silanes I., Lal A. and Gorospe M. (2005). HuR. Posttranscriptional paths to malignancy. RNA Biol. 2, e11-e13.
20. Monego G., Lauriola L., Ramella S., D'Angelillo R.M., Lanza P., Granone P. and Ranelletti F.O. (2010). Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 expression in human lung adenocarcinoma. Chest 137, 898-908.
21. Ranelletti F.O., Almadori G., Rocca B., Ferrandina G., Ciabattoni G., Habib A., Galli J., Maggiano N., Gessi M. and Lauriola L. (2001). Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. Int. J. Cancer (Pred. Oncol.) 95, 343-349.
22. Rebane A., Aab A. and Steitz J.A. (2004). Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR. RNA 10, 590-599.
23. Sato S., Nakamura Y. and Tsuchiya E. (1994). Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res. 54, 5652-5655.
24. Toschi L. and Cappuzzo F. (2009). Gemcitabine for the treatment of advanced nonsmall cell lung cancer. Onco Targets Ther. 2, 209-217.
25. Tran H., Maurer F. and Nagamine Y. (2003). Stabilization of urokinase and urokinase receptor mRNAs by HuR is linked to its cytoplasmic accumulation induced by activated mitogen-activated protein kinaseactivated protein kinase 2. Mol. Cell. Biol. 23, 7177-7188.
26. Travis W.D., Brambilla E., Muller-Hermelink H.K. and Harris C.C. (2004). Tumours of the lung, pleura, thymus and heart. Pathology & Genetics. World Health Organization Classification of Tumours. Lyon. IARC Press.
27. Travis W.D, Brambilla E., Noguchi M., Nicholson A.G., Geisinger K.R., Yatabe Y., Beer D.G., Powell C.A., Riely G.J., Van Schil P.E., Garg K., Austin J.H., Asamura H., Rusch V.W., Hirsch F.R., Scagliotti G., Mitsudomi T., Huber R.M., Ishikawa Y., Jett J., Sanchez-Cespedes M., Sculier J.P., Takahashi T., Tsuboi M., Vansteenkiste J., Wistuba I., Yang P.C., Aberle D., Brambilla C., Flieder D., Franklin W., Gazdar A., Gould M., Hasleton P., Henderson D., Johnson B., Johnson D., Kerr K., Kuriyama K., Lee J.S., Miller V.A., Petersen I., Roggli V., Rosell R., Saijo N., Thunnissen E., Tsao M. and Yankelewitz D. (2011). International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J. Thorac. Oncol. 6, 244-285.
28. Trodella L., Granone P., Valente S., Valentini V., Balducci M., Mantini G., Turriziani A., Margaritora S., Cesario A., Ramella S., Corbo G.M., D'Angelillo R.M., Fontana A., Galetta D. and Cellini N. (2002). Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother. Oncol. 62, 11-19.
29. Wang J., Zhao W., Guo Y., Zhang B., Xie Q., Xiang D., Gao J., Wang B. and Chen Z. (2009). The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis. Oncology 76, 420-429.
30. Wang J., Wang B., Bi J. and Zhang C. (2011). Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer. Med. Oncol. 28 (suppl. 1), 5577-5585.
31. Wang W., Caldwell M.C., Lin S., Furneaux H. and Gorospe M. (2000a). HuR regulates cyclin A and B1 mRNA stability during cell proliferation. EMBO J. 10, 2340-2350.
32. Wang W., Furneaux H., Cheng H., Caldwell M.C., Hutter D., Liu Y., Holbrook N. and Gorospe M. (2000b). HuR Regulates p21 mRNA Stabilization by UV Light. Mol. Cell. Biol. 20, 760-769.
33. Yang X., Wang W., Fan J., Lal A., Yang D., Cheng H. and Gorospe M. (2004). Prostaglandin A2-mediated stabilization of p21 mRNA through an ERK-dependent pathway requiring the RNA-binding protein HuR. J. Biol. Chem. 279, 49298-49306